Call for Abstract

3rd International Conference on Diagnostic Microbiology and Infectious Diseases , will be organized around the theme “The Role of Research in Diagnostic Microbiology,Infectious Diseases and Safety in Healthcare”

Diagnostic Microbiology-2018 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Diagnostic Microbiology-2018

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

Gastrointestinal infections are viral, bacterial or parasitic infections that cause gastroenteritis, an inflammation of the gastrointestinal tract involving both the stomach and the small intestine. Symptoms include diarrhea, vomiting, and abdominal pain. Dehydration is the main danger of gastrointestinal infections, so rehydration is important, but most gastrointestinal infections are self-limited and resolve within a few days. However, in a healthcare setting and in specific populations (newborns/infants, immunocompromized patients or elderly populations), they are potentially serious. Rapid diagnosis, appropriate treatment and infection control measures are therefore particularly important in these contexts.

 

  • Track 1-1Helicobacter Pylori Treatment
  • Track 1-2Gastrointestinal Disorders and Symptoms
  • Track 1-3Diagnosis of gastrointestinal disorders
  • Track 1-4Irritable Bowel Syndrome
  • Track 1-5Liver diseases
  • Track 1-6Cellular and Molecular Gastroenterology
  • Track 1-7Gut Microbiome

Skin infections are caused by a wide variety of germs, and symptoms can vary from mild to serious. 

  • Track 2-1Dermatological Diseases
  • Track 2-2Alopecia & Trichology
  • Track 2-3Sunburn
  • Track 2-4Skin Cancer
  • Track 2-5Allergy and Immunology
  • Track 2-6Melanoma
  • Track 2-7Cosmetic Dermatology
  • Track 2-8Skin-Toxico Pharmacology
  • Track 2-9Inflammatory Dermatopathology
  • Track 2-10Diagnosis in Dermatopathology
  • Track 2-11Skin Pigmentation

A urinary tract infection (UTI) is an infection from microbes. These are organisms that are too small to be seen without a microscope. Most UTIs are caused by bacteria, but some are caused by fungi and in rare cases by viruses. UTIs are among the most common infections in humans.

A UTI can happen anywhere in your urinary tract. Your urinary tract is made up of your kidneys, ureters, bladder, and urethra. Most UTIs only involve the urethra and bladder, in the lower tract. However, UTIs can involve the ureters and kidneys, in the upper tract. Although upper tract UTIs are more rare than lower tract UTIs, they’re also usually more severe.

 

  • Track 3-1Diagnosis of Kidney and Urinary Tract Disorders
  • Track 3-2Obstruction of The Urinary Tract
  • Track 3-3Kidney Failure
  • Track 3-4Disorders of Urination
  • Track 3-5Disorders of Kidney Tubules
  • Track 3-6Dialysis
  • Track 3-7Cystic Kidney Disorders
  • Track 3-8Cancers of the Kidney and Genitourinary Tract
  • Track 3-9Blood Vessel Disorders of The Kidneys
  • Track 3-10Urethritis
  • Track 3-11Stones in The Urinary Tract

Viral and immune mediated disorders of the nervous system are among the most challenging neurological disorders. The most common neuroimmune disorder is multiple sclerosis; and HIV is the most common viral infection of the nervous system. Common to both disorders is the progressive loss of neurons, resulting in significant cognitive and motor dysfunction. A major focus of Mayo researchers is to understand the pathophysiology of neuronal injury associated with these disorders to develop new diagnostic markers, therapeutic targets, and new areas of research applicable to other neurodegenerative diseases

  • Track 4-1Herpes simplex encephalitis
  • Track 4-2West Nile virus neurologic infections
  • Track 4-3Creutzfeldt–Jakob disease
  • Track 4-4Neurosarcoidosis
  • Track 4-5Polymerase chain reaction amplification of virus sequences from CSF specimens for diagnosis
  • Track 4-6Progressive multifocal leukoencephalopathy (PML)

Infectious diseases are caused by pathogenic microorganisms, such as bacteria, viruses, parasites or fungi; the diseases can be spread, directly or indirectly, from one person to another. Zoonotic diseases are infectious diseases of animals that can cause disease when transmitted to humans.

  • Track 5-1Bacterial and viral Infectious Diseases
  • Track 5-2Fungal and parasitic Infectious Diseases
  • Track 5-3Food-borne, air-borne and water-borne infectious diseases
  • Track 5-4Sexually transmitted diseases
  • Track 5-5Pediatric Infectious Disease
  • Track 5-6Communicable infectious diseases
  • Track 5-7Infections: Zika virus and Influenza (H1N1)

Diagnostic microbiology is the study of microbial identification. Since the discovery of the germ theory of disease, scientists have been finding ways to harvest specific organisms. Using methods such as differential media or genome sequencing, physicians and scientists can observe novel functions in organisms for more effective and accurate diagnosis of organisms. Methods used in diagnostic microbiology are often used to take advantage of a particular difference in organisms attain information about what species it might be, often through a reference of previous studies

  • Track 6-1Rapid antigen detection
  • Track 6-2Rapid identification after culture
  • Track 6-3Conventional tests
  • Track 6-4ELISA test
  • Track 6-5Molecular detection (nucleic acid probes and nucleic acid amplification)
  • Track 6-6Rapid biochemical tests
  • Track 6-7Direct microscopy
  • Track 6-8Radiology
  • Track 6-9Serology
  • Track 6-10Biomarkers
  • Track 6-11Molecular typing

COPD, or chronic obstructive pulmonary disease, is a progressive disease that makes it hard to breathe. Progressive means the disease gets worse over time.COPD can cause coughing that produces large amounts of a slimy substance called mucus, wheezing, shortness of breath, chest tightness, and other symptoms. Cigarette smoking is the leading cause of COPD. Most people who have COPD smoke or used to smoke. However, up to 25 percent of people with COPD never smoked. Long-term exposure to other lung irritants—such as air pollution, chemical fumes, or dusts—also may contribute to COPD. A rare genetic condition called alpha-1 antitrypsin (AAT) deficiency can also cause the disease.

  • Track 7-1Emphysema and chronic bronchitis
  • Track 7-2Signs and symptoms of COPD
  • Track 7-3Genetic Factors
  • Track 7-4Diagnosis of COPD
  • Track 8-1Oral Diseases
  • Track 8-2Diagnostic and Prognostic Tests for Oral Diseases
  • Track 8-3Gum Disease
  • Track 8-4Stages of Disease and Stage-Specific Diagnostic Information
  • Track 8-5Epidemiology of oral health
  • Track 8-6Delivery, management and promotion of oral health and dental care
  • Track 8-7Clinical Oral Healthcare Research
  • Track 9-1Cardiac Infection
  • Track 9-2Viral Myocarditis
  • Track 9-3Diagnosis & Tests for Cardiac Infection
  • Track 9-4Cardiac Infections: Focus on Molecular Diagnosis
  • Track 10-1Healthcare and Infectious Disease
  • Track 10-2Safety and Health Administration
  • Track 10-3Infection Risks in The Healthcare Setting
  • Track 10-4Healthcare and Hospital Management

Immunology is the study of the immune system and is a very important branch of the medical and biological sciences, that deals with the response of an organism to antigenic challenge and its recognition of what is self and what is not. By understanding how pathogens cause disease helps in the development of new therapeutic approaches. Virulence is the measure of the pathogenicity of an organism. The degree of virulence is related directly to the ability of the organism to cause infection despite host resistance mechanisms, it is affected by numerous variables such as the number of infecting bacteria, route of entry into the body, specific and nonspecific host defence mechanisms and virulence factors of the bacterium.

  • Track 12-1Clinical immunology
  • Track 12-2Virulence factor
  • Track 12-3Infection and immunity
  • Track 12-4Host- microbe interaction and biology
  • Track 12-5Inflammation
  • Track 12-6Immunology of diseases
  • Track 12-7Microbial pathogenesis
  • Track 12-8Development of vaccine

Treatment and therapeutics of infectious diseases  involves patient care and moral support including therapy, medicine and antimicrobial agent. Bacterial infections can be treated by administering antibiotics to the patients. Yeast infections can be primarily treated by sterilisation methods. Parasitic infections can be treated by antiparasitic drugs. Diseases such as cancer can be treated by chemotherapy. Recent techniques have proved that there is no disease that cannot be treated.

  • Track 13-1Antimicrobial agent
  • Track 13-2Chemotherapeutic agent
  • Track 13-3Traditional medicine
  • Track 13-4Vaccine and vaccination
  • Track 13-5Molecular therapeutics
  • Track 13-6Biopharmaceutical Product
  • Track 13-7Herbal treatment
  • Track 13-8Chemotherapy
  • Track 13-9Antibiotics and antiseptics
  • Track 13-10Anti-inflammatory drugs

The epidemiology of infectious disease (ID) involves study of the prevalence, incidence and determinants of infections in populations. Infectious diseases remain one of the most important causes of morbidity and mortality around the world.  In addition to studying the rates of and risk factors for infectious disease, ID epidemiologists implement and evaluate interventions at the individual and community level to: prevent infection (primary prevention) and, among those with infections, to prevent development of disease (secondary prevention) or disease-associated death and disability (tertiary prevention).

  • Track 14-1Infectious disease epidemiology
  • Track 14-2Case control studies in infectious disease epidemiology
  • Track 14-3Cancers of public health significance
  • Track 14-4Specific Chronic Diseases
  • Track 14-5Disease surveillance
  • Track 14-6Importance for public health, epidemiology, promoting factors, and prevention

The microbial world is complex, dynamic, and constantly emerging. Infection causing organisms reproduce rapidly, mutate frequently and adapt with relative ease to their new surroundings. Because of these characteristics, infectious organisms are able to alter their epidemiology, their virulence, and their susceptibility to anti-infective drugs. All forms of infectious organisms—bacteria, viruses, parasites, and prions are able to emerge or re-emerge in human populations, and it is estimated that up to 70 per cent or more of all emerging infections have a source in animals.

  • Track 15-1Cellular and Molecular Gastroenterology
  • Track 15-2Detection of new microbes
  • Track 15-3Epidemiology, organisms involved and transmission
  • Track 15-4Disease reservoirs
  • Track 15-5Nosocomial infection
  • Track 15-6Direct and indirect mode of transmission
  • Track 15-7The challenge of emerging and re-emerging infectious diseases
  • Track 15-8Relationship between virulence and survival

Infection control is the discipline concerned with preventing nosocomial or healthcare-associated infection, a practical sub-discipline of epidemiology. It is an essential, though often under recognized and under supported, part of the infrastructure of health care. Infection control and hospital epidemiology are akin to public health practice, practiced within the confines of a particular health-care delivery system rather than directed at society as a whole. Anti-infective agents include antibiotics, antibacterials, antifungals, antivirals and antiprotozoals.

  • Track 16-1Infection control and health care epidemiology
  • Track 16-2Infection prevention and control guidelines
  • Track 16-3National Healthcare Safety Network (NHSN)
  • Track 16-4Antimicrobial and chemotherapeutic agent
  • Track 16-5Safe injection practices

Clinical Microbiology is a branch of medical science concerned with the prevention, diagnosis and treatment of infectious diseases. Moreover, this field of science is concerned about various clinical applications of microbes for the improvement of health.

  • Track 17-1Clinical analysis or clinical biology
  • Track 17-2Toxicology
  • Track 17-3Specific groups of microbial pathogens
  • Track 17-4Control of antibiotic resistance strains and MDR strains

The  molecular  mechanisms of  infectious  disease  and identify potential therapeutic and diagnostic targets by exploiting next-generation genomic data.  It focuses on the comparative analysis of genomes obtained from local clinical isolates of important  pathogens such as  Mycobacterium  tuberculosis, Pseudomonas aeruginosa, Staphylococci, Campylobacter, Streptococci, ,and  Acinetobacter baumannii  and many other microorganisms.

  • Track 18-1Microbial whole genome sequencing
  • Track 18-2Bioinformatics
  • Track 18-3Functional genomics
  • Track 18-4Genome comparisons and phylogeny